Apotex Inc - Company Profile
Powered by 
All the sales intelligence you need on Apotex Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Apotex Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Apotex Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Apotex Inc (Apotex) develops and manufactures generic pharmaceuticals. The company also offers biosimilars, active pharmaceutical ingredients, and consumer products. It carries out the research, development, manufacture, and distribution of non-prescription and private label medicines, fine chemicals, and disposable plastics for medical use. The company serves patients, healthcare providers and payers, governments, and other pharmaceutical manufacturers. The company operates through subsidiaries, joint ventures and licensing agreements across the Americas, Europe, the Middle East, Africa, and Asia Pacific. Apotex is headquartered in Toronto, Ontario, Canada.
Headquarters
Canada
Address
150 Signet Drive, Toronto, Ontario, M9L1T9
Website
www1.apotex.com
Telephone
1 800 2684623
No of Employees
6,000
Industry
Pharmaceuticals and Healthcare
Apotex Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Generic Pharmaceuticals | Apixaban |
| Non-Prescription Medicines | Apo-Deferasirox |
| Private Label Medicines | Deferasirox (Type J) |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | New Products/Services | In May, the company announced the launch of nilotinib capsules, the first generic version of Tasigna in the US. |
| 2025 | New Products/Services | In May, the company announced the launch of IVRA (Melphalan) hydrochloride injection in the US. |
| 2025 | Acquisitions/Mergers/Takeovers | In February, the company acquired CanPrev. |
Competitor Comparison
| Key Parameters | Apotex Inc | Duchesnay Inc | Eloxx Pharmaceuticals Inc | Liminal BioSciences Inc | Resilience Biotechnologies Inc |
|---|---|---|---|---|---|
| Headquarters | Canada | Canada | United States of America | Canada | United States of America |
| City | Toronto | Blainville | Arlington | Laval | La Jolla |
| State/Province | Ontario | Quebec | Massachusetts | Quebec | California |
| No. of Employees | 6,000 | - | 10 | - | - |
| Entity Type | Private | Private | Public | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Jeff Watson | Director; President; Chief Executive Officer | Executive Board | 2026 | - |
| Brian McClelland | Chief Financial Officer | Senior Management | 2023 | - |
| Ariel Alon | Chief Operating Officer | Senior Management | 2023 | - |
| Francesco Tallarico | Chief Legal Officer; Head - Government Relations | Senior Management | 2023 | - |
| Barry Fishman | Chief Corporate Development Officer | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer